Paper · 19436645
Vascular calcifications as a marker of increased cardiovascular risk: a meta-analysis.
Rennenberg RJ and 5 others. Vasc Health Risk Manag, 2009. Cited by 386 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Vascular calcifications as a marker of increased cardiovascular risk: a meta-analysis. Papers, record 19436645. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19436645
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Calcinosis | Major topic |
| Cardiovascular Diseases | Major topic |
| Coronary Artery Disease | Major topic |
| Heart Valve Diseases | Major topic |
| Peripheral Vascular Diseases | Major topic |
| Coronary Disease | |
| Diagnostic Imaging | |
| Humans | |
| Kidney Failure, Chronic | |
| Odds Ratio | |
| Predictive Value of Tests | |
| Reproducibility of Results | |
| Risk Assessment | |
| Risk Factors | |
| Stroke | |
| Time Factors |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15,944,423 | A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. | N Engl J Med | 2005 | https://conductscience.org/library/papers/15944423 | PubMed |
| 2 | 15,226,161 | Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and meta-analysis. | Arch Intern Med | 2004 | https://conductscience.org/library/papers/15226161 | PubMed |
| 3 | 15,961,706 | Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification. | Arterioscler Thromb Vasc Biol | 2005 | https://conductscience.org/library/papers/15961706 | PubMed |
| 4 | 14,722,147 | Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. | JAMA | 2004 | https://conductscience.org/library/papers/14722147 | PubMed |
| 5 | 12,360,172 | Abdominal aortic calcific deposits are associated with increased risk for congestive heart failure: the Framingham Heart Study. | Am Heart J | 2002 | https://conductscience.org/library/papers/12360172 | PubMed |
| 6 | 12,958,327 | Comparison between measures of atherosclerosis and risk of stroke: the Rotterdam Study. | Stroke | 2003 | https://conductscience.org/library/papers/12958327 | PubMed |
| 7 | 11,823,653 | Stroke is associated with coronary calcification as detected by electron-beam CT: the Rotterdam Coronary Calcification Study. | Stroke | 2002 | https://conductscience.org/library/papers/11823653 | PubMed |
| 8 | 16,449,511 | Progressive coronary calcification despite intensive lipid-lowering treatment: a randomised controlled trial. | Heart | 2006 | https://conductscience.org/library/papers/16449511 | PubMed |
| 9 | 15,992,652 | Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial. | J Am Coll Cardiol | 2005 | https://conductscience.org/library/papers/15992652 | PubMed |
| 10 | 10,694,523 | Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. | Circulation | 2000 | https://conductscience.org/library/papers/10694523 | PubMed |
1 to 10 of 47
See all 47 referencesCited by220
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 386 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,941,360 | Association Between Breast Arterial Calcification on Mammography and Carotid Artery Stenosis on CT Angiography: A Retrospective Study in a Selected Cohort of Women Aged 60-65 Years. | J Clin Med | 2026 | https://conductscience.org/library/papers/42941360 | PubMed |
| 42,889,018 | Inverse association between the extracellular matrix protein Tenascin-X and concurrent abdominal aortic calcification in patients with primary aldosteronism. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42889018 | PubMed |
| 42,754,899 | Predictive nomogram for abdominal aortic calcification risk: a multi-algorithm approach integrating demographic and clinical variables. | J Cardiothorac Surg | 2026 | https://conductscience.org/library/papers/42754899 | PubMed |
| 42,333,862 | Emerging biomedical and pharmaceutical strategies for the treatment of atherosclerosis: from conventional lipid-lowering therapy to nanomedicine. | J Appl Biomed | 2026 | https://conductscience.org/library/papers/42333862 | PubMed |
| 42,315,532 | Elastin calcification during the initial stage of vascular calcification in kl/kl mice is suppressed by the calcimimetic upacicalcet. | Sci Rep | 2026 | https://conductscience.org/library/papers/42315532 | PubMed |
| 42,209,748 | Review of breast arterial calcifications for cardiovascular disease risk prediction. | NPJ Cardiovasc Health | 2026 | https://conductscience.org/library/papers/42209748 | PubMed |
| 42,020,826 | Adipose-Derived Proinflammatory Visfatin Promotes Vascular Calcification via TLR4 and is Suppressed by Empagliflozin. | Inflammation | 2026 | https://conductscience.org/library/papers/42020826 | PubMed |
| 41,903,889 | Magnesium supplementation did not reduce serum calciprotein crystallization and arterial stiffness in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. | Am J Clin Nutr | 2026 | https://conductscience.org/library/papers/41903889 | PubMed |
| 41,772,492 | Automated opportunistic cardiovascular risk assessment in non-small cell lung cancer patients on routine chest CT using an optimised nnU-net framework. | BMC Med Imaging | 2026 | https://conductscience.org/library/papers/41772492 | PubMed |
| 41,593,503 | Rat models for arterial calcification associated with chronic kidney disease: a systematic review and meta-analysis. | BMC Cardiovasc Disord | 2026 | https://conductscience.org/library/papers/41593503 | PubMed |
1 to 10 of 220
See all 220 cited byGenes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| MGP | 4,256 | PubTator's text mining | https://conductscience.org/library/genes/4256 |
Source NCBI Gene
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19436645
GET https://conductscience.org/api/papers/v1/19436645/references?page=2